https://www.zacks.com/stock/news/2330828/advansix-asix-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2330828
Sep 03, 2024 - When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
zc:-4915128972465387601
0
https://www.cnbc.com/2024/09/03/golden-era-for-hong-kong-retail-is-over-as-chinese-tourists-continue-to-tighten-their-purse-strings.html
Sep 03, 2024 - Real estate analysts claimed that the shopping frenzy the city once experienced will not return "for a long, long time."
0
cnbc:8019566025044859564
0
https://www.zacks.com/stock/news/2330748/beat-the-market-like-zacks-caredx-fair-isaac-3m-in-focus?cid=CS-ZC-FT-analyst_blog|investment_ideas-2330748
Sep 03, 2024 - Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
zc:-4595681074380677955
0
https://www.wired.com/story/ski-resorts-are-stockpiling-snow-to-get-through-warm-winters/
Sep 03, 2024 - Under protective coverings, piles of snow can be stored for a surprisingly long time, allowing ski resorts to mitigate some of the lack of snowfall caused by climate change.
0
wr:3148090263762654730
0
https://www.ocregister.com/2024/09/02/dodgers-shohei-ohtani-returns-to-anaheim-amid-playoff-race-50-50-chase/
Sep 02, 2024 - Ohtani has already faced the Angels several times during spring training and in the regular season at Dodger Stadium, but this week’s games at the Big A are another reminder of his present vs. his past.
0
ocr:-3095822164884825887
0
https://www.zacks.com/stock/news/2330532/earnings-estimates-moving-higher-for-new-york-times-nyt-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2330532
Sep 02, 2024 - New York Times (NYT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:7050830708911920093
0
https://www.zacks.com/stock/news/2330528/earnings-estimates-moving-higher-for-datadog-ddog-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2330528
Sep 02, 2024 - Datadog (DDOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:-2450027878589224350
0
https://www.zacks.com/stock/news/2330534/earnings-estimates-moving-higher-for-abercrombie-anf-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2330534
Sep 02, 2024 - Abercrombie (ANF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:4292157165809668502
0
https://www.zacks.com/stock/news/2330169/nvidia-s-data-center-sales-rise-154-in-q2-time-to-buy-the-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2330169
Sep 02, 2024 - NVDA's long-term growth story is compelling, but issues like product delays and lofty valuations imply that now may not be the ideal time to buy aggressively.
zc:6902748625271002824
0
https://www.zacks.com/stock/news/2330244/sny-s-ms-drug-meets-goal-in-one-phase-iii-study-misses-in-two-others?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2330244
Sep 02, 2024 - Sanofi's HERCULES phase III study on tolebrutinib meets primary endpoint, showing an improvement in delaying time to onset of confirmed disability progression.
zc:-4072521715241542313
0